Allezoe Medical says executive wrote affidavit for lawsuit opponent | Personnel Roundup

March 8, 2012 By MassDevice staff Leave a Comment

Allezoe Medical Holdings (OTC:ALZM) said board member and secretary Hyman White broke its internal rules and possibly state and federal laws when he wrote an affidavit supporting the un-named plaintiff in a lawsuit filed against Allezoe.

The medical device maker, which just completed a reverse merger of Organ Transport Systems after just 1 year, said White wrote the affidavit “in consultation with plaintiff and plaintiff’s legal counsel, and possibly other senior management of Organ Transport Systems Inc., but without prior disclosure to or consent from management, the board of directors or legal counsel for the company,” according to a regulatory filing.

“This appears to be a breach of Mr. White’s fiduciary obligation to the company and his duties and responsibilities under our code of ethics and guidelines for corporate governance. This conduct also may constitute a violation of his agreed undertaking and obligation to the company, as a publicly reporting and trading company, to act in good faith and without conflicts of interest,” according to the filing. “In addition … it appears that Mr. White’s conduct could also constitute a violation of federal and state securities laws, including the Sarbanes-Oxley Act. To the extent that the audit committee receives evidence or concludes that the latter is the case, then that evidence and the related facts would have to be forwarded to the appropriate authorities for consideration of any further action they may wish to take.”

Sign up to get our free newsletters delivered straight to your inbox

White founded Organ Transport Systems, which the company’s website still calls “Allezoe’s flagship holding in the medical technology sector.” Allezoe bought OTS from Healthcare of Today a year ago, but reversed course and sold it back this month.

Allezoe said the basis of the lawsuit, with which it hasn’t yet been served, “although not very clear, appears to relate to a promissory note issued by Healthcare of Today Inc. to the plaintiff in the case, which note is identical with a promissory note issued to Mr. White and to other officers and directors of Organ Transport Systems Inc.”

“It also appears that statements made by Mr. White in his affidavit appear to be knowingly false and adverse to the interests of the company,” according to the filing, which notes that the lawsuit appears to claim that shareholders of OTS “should now be considered shareholders” of Allezoe.

“The basis for this unusual claim is not clear, but seems to be based on the fact that Healthcare of Today Inc. later (February 2011) transferred the shares of OTS it acquired from the OTS shareholders in June 2010, to [Allezoe], as a result of which OTS became a wholly-owned subsidiary of [Allezoe],” the company said.

Allezoe said its audit committee is launching a probe into the affair, which will also look into “the facts relating to an earlier attempt to bind the company to onerous employment contracts, with expensive and unwarranted ‘golden parachute’ provisions for Mr. White and other management of Organ Transport Systems Inc. then serving also as officers or directors of [Allezoe].”

White

The investigation will also consider “the potential use of corporate funds other than for the best interests of the company,” “the possible disclosure of corporate information to unauthorized third parties, including former creditors or shareholders of OTS, stock marketing entities, blog sites and similar stock promoters and manipulators” and whether White or any other officers or directors of OTS had a hand in “instigating, promoting, or aiding and abetting the filing and prosecution of the lawsuit for Mr. White’s own personal benefit or the personal benefit of other officers or directors of OTS,” according to the filing.

Biolase names sales & marketing veep

Biolase Technology promoted international vice president William Brown to VP of sales & marketing. Read more

SynCardia taps new COO

SynCardia Systems Inc. named Douglas Nutter to be its new operations chief. Read more

Mojo Vision developing ‘smart’ contact lens
Mojo Vision is working with the FDA to develop a smart contact lens to help people with low vision. The lens overlays real-time contrast and lighting enhancements with zoom functionality and recently won FDA breakthrough device designation. “Receiving the Breakthrough Device Designation is a significant step in our research and development process. We look forward to… […]
FDA to EPA: Leave us out of your ethylene oxide rule
This article has been updated with comments from the FDA. The FDA has asked the Environmental Protection Agency to leave the FDA out of its proposal for stricter regulation of ethylene oxide (EtO) emissions, and the EPA complied. In an interagency comment on the EPA’s proposed rule governing commercial EtO users — which includes medical… […]
Clippart debuts stepper-controlled flow valve
Clippard recently launched a new stepper-controlled proportional valve for precision flow control. The Eclipse valve uses the industry’s most robust and powerful miniature linear actuator, according to Cincinnati-based Clippard. The patent-pending Eclipse is designed for liquid and gas delivery, medical, analytical and industrial automation requiring ultra-fine resolution and repeatability. The design also allows for custom… […]
Supporting regulatory affairs departments to address clinical requirements under new MDR
By Dietmar Falke and Jaap Laufer, Emergo Group The May 25, 2020 MDR deadline is approaching rapidly, and by now many medical device manufacturers are aware that the MDR requires the proactive collection of post-marketing clinical follow-up (PMCF) data. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog… […]
5 tips to raise funding for your medical device
Securing funding can be a long and tedious process, and medical device businesses must work to position themselves as especially attractive to potential investors to maximize success and accelerate the fundraising process. Jon Speer, Greenlight Guru According to Alejandro Cremades, author of The Art of Startup Fundraising, it can take from six to nine months… […]
FDA recognizes latest ISO 14971 as medical device consensus standard
By Mark Leimbeck and Stewart Eisenhart, Emergo Group The US Food and Drug Administration has granted Recognized Consensus Standard status to the third edition of the ISO 14071 risk management standard for medical devices and IVD products. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post are… […]
Synaptive Medical updates Modus V surgical microscope
Synaptive Medical announced that its U.S. and Canadian Modus V robotic digital microscope now includes updates such as additional 3D visualization and voice-activated control. The Modus V is a robotically controlled digital microscope used as part of Synaptive’s BrightMatter surgical suite designed for less invasive, patient-specific approaches in complex cranial procedures. The Modus V provides similar… […]
New machine can preserve donor livers for 1 week
Researchers in Switzerland have built a perfusion machine that can preserve human livers for transplantation for a week or more, potentially slashing the number of donor livers that must be discarded due to time-related deterioration. Existing perfusion technology can preserve a donor liver for up to 24 hours. The team of surgeons, biologists and engineers… […]
Smiths Medical launches Portex tracheostomy tubes and kits
Smiths Medical this week launched its Portex polyvinyl chloride tracheostomy tube and kit portfolio. The new polyvinyl chloride (PVC) tube portfolio has options for a variety of patients, according to the company. “Our goal was to create tracheostomy tubes and kits designed to help clinicians provide the best patient care. We’re excited to offer a variety… […]
FDA clears Cleveland Clinic 3D-printed airway stents
The FDA recently cleared 3D-printed, patient-specific stents developed by a doctor at the Cleveland Clinic. Cleveland Clinic physician Tom Gildea developed the stents to keep open the airways of patients with serious breathing disorders caused by inflammation, trauma, tumors and other masses. Airway stents come in a limited number of sizes and shapes and are… […]
Boston Scientific shares drop on Q4 sales news
Shares in Boston Scientific (NYSE:BSX) dropped 8% this morning on news of disappointing fourth-quarter sales. The company’s preliminary earnings report showed sales for the quarter ended Dec. 31, 2019 coming in at $2.9 billion, below the $2.91 billion that analysts were expecting. The unaudited sales figure represents organic growth of 7.3%, missing the company’s own guidance of… […]